Shares of Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.72 and traded as low as $1.65. Aemetis shares last traded at $1.72, with a volume of 726,310 shares traded.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the company. StockNews.com upgraded Aemetis to a "sell" rating in a research report on Wednesday, February 5th. HC Wainwright reissued a "buy" rating and set a $28.00 price objective on shares of Aemetis in a report on Monday, December 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $14.56.
View Our Latest Analysis on Aemetis
Aemetis Stock Down 3.4 %
The stock has a 50-day simple moving average of $2.29 and a two-hundred day simple moving average of $2.70. The firm has a market cap of $85.94 million, a PE ratio of -0.74 and a beta of 1.48.
Institutional Trading of Aemetis
Several hedge funds and other institutional investors have recently bought and sold shares of the company. ProShare Advisors LLC bought a new stake in shares of Aemetis in the 4th quarter worth approximately $27,000. Tower Research Capital LLC TRC lifted its stake in Aemetis by 128.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company's stock worth $28,000 after purchasing an additional 5,859 shares during the last quarter. Voya Investment Management LLC purchased a new stake in Aemetis during the fourth quarter valued at about $28,000. Clear Harbor Asset Management LLC purchased a new stake in Aemetis during the fourth quarter valued at about $44,000. Finally, Intech Investment Management LLC bought a new position in shares of Aemetis during the fourth quarter valued at about $46,000. Hedge funds and other institutional investors own 27.02% of the company's stock.
Aemetis Company Profile
(
Get Free Report)
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Read More
Before you consider Aemetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.
While Aemetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.